William Bhatt

William Bhatt specializes in hepatic arterial infusion pump chemotherapy for colorectal liver metastases at UCSF, an approach that delivers high drug concentrations directly to the liver while minimizing systemic toxicity. His research has evaluated HAI pump floxuridine in combination with systemic chemotherapy to convert unresectable liver metastases to resectable disease. He has contributed to optimizing patient selection, drug dosing, and safety monitoring for HAI pump programs. His work bridges interventional radiology and hepatic surgical oncology.